Blanca Martínez de Las Heras, Pedro M Rubio-Aparicio, Alba Rubio-San-Simón, Lucas Moreno, Paula Mazorra, Ricardo López Almaraz, Mercedes Llempén López, Julia Balaguer Guill, Vanessa Segura, Mar Bermúdez, Irene Jiménez, Désirée Ramal, Adela Cañete
{"title":"纠正:儿童高危神经母细胞瘤的治疗和结局:来自西班牙儿科血液与肿瘤学会(SEHOP)神经母细胞瘤组对难治性和复发/进展性疾病的见解。","authors":"Blanca Martínez de Las Heras, Pedro M Rubio-Aparicio, Alba Rubio-San-Simón, Lucas Moreno, Paula Mazorra, Ricardo López Almaraz, Mercedes Llempén López, Julia Balaguer Guill, Vanessa Segura, Mar Bermúdez, Irene Jiménez, Désirée Ramal, Adela Cañete","doi":"10.1007/s12094-025-03912-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction: Management and outcome of children with high‑risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.\",\"authors\":\"Blanca Martínez de Las Heras, Pedro M Rubio-Aparicio, Alba Rubio-San-Simón, Lucas Moreno, Paula Mazorra, Ricardo López Almaraz, Mercedes Llempén López, Julia Balaguer Guill, Vanessa Segura, Mar Bermúdez, Irene Jiménez, Désirée Ramal, Adela Cañete\",\"doi\":\"10.1007/s12094-025-03912-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":50685,\"journal\":{\"name\":\"Clinical & Translational Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12094-025-03912-2\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03912-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Correction: Management and outcome of children with high‑risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.
期刊介绍:
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.